Three vaccines of the corona virus are being trialled on humans in India. One of them is a foreign vaccine developed by researchers at Oxford University and pharma company AstraZeneca. Trial and manufacturing of this vaccine has been signed with Serum Institute of India AstraZeneca, Pune. Let me tell you that this vaccine will be available in the name of 'Kovishield'. Currently, phase 2 trials are going on in India. Vaccine double blind, randomized trials are being conducted at 53 volunteers at PGI, Chandigarh. Up to a week after the first dose, volunteers have not seen any side effects.